Polyamines and cancer: old molecules, new understanding (original) (raw)

• Cohen, S. S. A Guide to the Polyamines. (Oxford Univ. Press, New York, 1998).
  Google Scholar
• Morris, S. M. Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Annu. Rev. Nutr. 22, 87–105 (2002).
  Article CAS PubMed Google Scholar
• Bardocz, S. et al. The importance of dietary polyamines in cell regeneration and growth. Br. J. Nutr. 73, 819–828 (1995).
  Article CAS PubMed Google Scholar
• Milovic, V. Polyamines in the gut lumen: bioavailability and biodistribution. Eur. J. Gastroenterol. Hepatol. 13, 1021–1025 (2001).
  Article CAS PubMed Google Scholar
• Tabor, H., Hafner, E. W. & Tabor, C. W. Construction of an Escherichia coli strain unable to synthesize putrescine, spermidine, or cadaverine: characterization of two genes controlling lysine decarboxylase. J. Bacteriol. 144, 952–956 (1980).
  CAS PubMed PubMed Central Google Scholar
• Tabor, C. W., Tabor, H., Tyagi, A. K. & Cohn, M. S. The biochemistry, genetics, and regulation of polyamine biosynthesis in Saccharomyces cerevisiae. Fed. Proc. 41, 3084–3088 (1982).
  CAS PubMed Google Scholar
• Pendeville, H. et al. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol. Cell. Biol. 21, 6549–6558 (2001). Showed that ODC is an essential gene in mammals and that lack of ODC function resulted in increased apoptosis in developing embryos.
  Article CAS PubMed PubMed Central Google Scholar
• Chang, Z. F. & Chen, K. Y. Regulation of ornithine decarboxylase and other cell cycle-dependent genes during senescence of IMR-90 human diploid fibroblasts. J. Biol. Chem. 263, 11431–11435 (1988).
  CAS PubMed Google Scholar
• Gerner, E. W., Garewal, H. S., Emerson, S. S. & Sampliner, R. E. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with α-difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev. 3, 325–330 (1994).
  CAS PubMed Google Scholar
• Russell, D. & Snyder, S. H. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc. Natl Acad. Sci. USA 60, 1420–1427 (1968).
  Article CAS PubMed PubMed Central Google Scholar
• Andersson, G. & Heby, O. Polyamine and nucleic acid concentrations in Ehrlich ascites carcinoma cells and liver of tumor-bearing mice at various stages of tumor growth. J. Natl Cancer Inst. 48, 165–172 (1972).
  CAS PubMed Google Scholar
• Wallace, H. M. & Caslake, R. Polyamines and colon cancer. Eur. J. Gastroenterol. Hepatol. 13, 1033–1039 (2001).
  Article CAS PubMed Google Scholar
• O'Brien, T. G., Simsiman, R. C. & Boutwell, R. K. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res. 35, 1662–1670 (1975).
  CAS PubMed Google Scholar
• Ahmad, N., Gilliam, A. C., Katiyar, S. K., O'Brien, T. G. & Mukhtar, H. A definitive role of ornithine decarboxylase in photocarcinogenesis. Am. J. Pathol. 159, 885–892 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Marsh, J. P. & Mossman, B. T. Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster tracheal epithelial cells. Cancer Res. 51, 167–173 (1991).
  CAS PubMed Google Scholar
• Crozat, A., Palvimo, J. J., Julkunen, M. & Janne, O. A. Comparison of androgen regulation of ornithine decarboxylase and _S_-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs. Endocrinology 130, 1131–1144 (1992).
  CAS PubMed Google Scholar
• Mohan, R. R. et al. Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin. Cancer Res. 5, 143–147 (1999).
  CAS PubMed Google Scholar
• Meyskens, F. L. Jr. & Gerner, E. W. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin. Cancer Res. 5, 945–951 (1999).
  CAS PubMed Google Scholar
• Thomas, T., Faaland, C. A., Adhikarakunnathu, S. & Thomas, T. J. Structure-activity relations of _S_-adenosylmethionine decarboxylase inhibitors on the growth of MCF-7 breast cancer cells. Breast Cancer Res. Treat. 39, 293–306 (1996).
  Article CAS PubMed Google Scholar
• Casero, R. A. Jr. et al. The role of polyamine catabolism in anti-tumour drug response. Biochem. Soc. Trans. 31, 361–365 (2003).
  Article CAS PubMed Google Scholar
• Eskens, F. A. et al. Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group. Clin. Cancer Res. 6, 1736–1743 (2000).
  CAS PubMed Google Scholar
• Wolff, A. C. et al. A Phase II study of the polyamine analog _N_1,_N_11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin. Cancer Res. 9, 5922–5928 (2003).
  CAS PubMed Google Scholar
• Giardiello, F. M. et al. Ornithine decarboxylase and polyamines in familial adenomatous polyposis. Cancer Res. 57, 199–201 (1997). Showed that colonic ODC activity and polyamine levels were increased in patients with FAP, a genetic form of colon cancer.
  CAS PubMed Google Scholar
• Groden, J. et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589–600 (1991).
  Article CAS PubMed Google Scholar
• Kinzler, K. W. et al. Identification of FAP locus genes from chromosome 5q21. Science 253, 661–665 (1991).
  Article CAS PubMed Google Scholar
• Iwamoto, M., Ahnen, D. J., Franklin, W. A. & Maltzman, T. H. Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis 21, 1935–1940 (2000).
  Article CAS PubMed Google Scholar
• He, T. C. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509–1512.
  Article CAS PubMed Google Scholar
• Boyd, K. E. & Farnham, P. J. Identification of target genes of oncogenic transcription factors. Proc. Soc. Exp. Biol. Med. 222, 9–28 (1999).
  Article CAS PubMed Google Scholar
• Hermeking, H. The MYC oncogene as a cancer drug target. Curr. Cancer Drug Targets 3, 163–175 (2003).
  Article CAS PubMed Google Scholar
• Bello-Fernandez, C., Packham, G. & Cleveland, J. L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl Acad. Sci. USA 90, 7804–7808 (1993). Showed that ODC is a transcriptional target of the MYC oncogene
  Article CAS PubMed PubMed Central Google Scholar
• Pena, A. et al. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J. Biol. Chem. 268, 27277–27285 (1993).
  CAS PubMed Google Scholar
• Erdman, S. H. et al. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis 20, 1709–1713 (1999). Demonstrated that ODC RNA was upregulated, OAZ RNA was downregulated and intestinal polyamine content increased as a consequence of loss of wild-type APC in a mouse model.
  Article CAS PubMed Google Scholar
• Fultz, K. E. & Gerner, E. W. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Mol. Carcinog. 34, 10–18 (2002).
  Article CAS PubMed Google Scholar
• Shantz, L. M. & Pegg, A. E. Ornithine decarboxylase induction in transformation by H-Ras and RhoA. Cancer Res. 58, 2748–2753 (1998).
  CAS PubMed Google Scholar
• Smith, M. K., Trempus, C. S. & Gilmour, S. K. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 19, 1409–1415 (1998).
  Article CAS PubMed Google Scholar
• Ignatenko, N. A., Babbar, N., Mehta, D., Casero, R. A. Jr & Gerner, E. W. Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells. Mol. Carcinog. 39, 91–102 (2004).
  Article CAS PubMed Google Scholar
• Babbar, N., Ignatenko, N. A., Casero, R. A. Jr & Gerner, E. W. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J. Biol. Chem. 278, 47762–47775 (2003). Established SSAT as a transcriptional target of the PPARγ tumour suppressor and showed that the sulphone metabolite of the NSAID sulindac induced SSAT transcription by activating PPARγ.
  Article CAS PubMed Google Scholar
• Bai, G. et al. Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells. J. Androl. 19, 127–135 (1998).
  CAS PubMed Google Scholar
• De Benedetti, A. & Harris, A. L. eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31, 59–72 (1999).
  Article CAS PubMed Google Scholar
• Martinez, M. E. et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc. Natl Acad. Sci. USA 100, 7859–7864 (2003). Showed that an SNP in the ODC promoter was associated, with reduced risk of colon-polyp recurrence in people reporting aspirin use. Provided evidence that the ODC SNP reduced polyamine synthesis, while aspirin induced polyamine catabolism and export, thereby reducing polyamine levels.
  Article CAS PubMed PubMed Central Google Scholar
• Ignatenko, N. A. et al. The chemopreventive agent α-difluoromethylornithine blocks K-ras dependent tumor formation and specific gene expression in Caco-2 cells. Mol. Carcinog. 39, 221–233 (2004).
  Article CAS PubMed Google Scholar
• Brzozowski, T., Konturek, S. J., Drozdowicz, D., Dembinski, A. & Stachura, J. Healing of chronic gastric ulcerations by L-arginine. Role of nitric oxide, prostaglandins, gastrin and polyamines. Digestion. 56, 463–471 (1995).
  Article CAS PubMed Google Scholar
• Xie, X., Tome, M. E. & Gerner, E. W. Loss of intracellular putrescine pool-size regulation induces apoptosis. Exp. Cell Res. 230, 386–392 (1997).
  Article CAS PubMed Google Scholar
• Erez, O., Goldstaub, D., Friedman, J. & Kahana, C. Putrescine activates oxidative stress dependent apoptotic death in ornithine decarboxylase overproducing mouse myeloma cells. Exp. Cell Res. 281, 148–156 (2002).
  Article CAS PubMed Google Scholar
• Takigawa, M. et al. Tumor angiogenesis and polyamines: α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro. Cancer Res. 50, 4131–4138 (1990).
  CAS PubMed Google Scholar
• Takahashi, Y., Mai, M. & Nishioka, K. α-difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model. Int. J. Cancer 85, 243–247 (2000).
  Article CAS PubMed Google Scholar
• Bauer, P. M., Buga, G. M., Fukuto, J. M., Pegg, A. E. & Ignarro, L. J. Nitric oxide inhibits ornithine decarboxylase via _S_-nitrosylation of cysteine 360 in the active site of the enzyme. J. Biol. Chem. 276, 34458–34464 (2001).
  Article CAS PubMed Google Scholar
• Buga, G. M., Wei, L. H., Bauer, P. M., Fukuto, J. M. & Ignarro, L. J. (1998) NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol. 275, R1256–R1264.
• Itoh, M. & Bissell, M. J. The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis. J. Mammary Gland Biol. Neoplasia 8, 449–462 (2003).
  Article PubMed PubMed Central Google Scholar
• Trosko, J. E. The role of stem cells and gap junctional intercellular communication in carcinogenesis. J. Biochem. Mol. Biol. 36, 43–48 (2003).
  CAS PubMed Google Scholar
• Guo, X. et al. Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines. Am. J. Physiol. Cell Physiol. 285, C1174–C1187 (2003).
  Article CAS PubMed Google Scholar
• Shore, L., McLean, P., Gilmour, S. K., Hodgins, M. B. & Finbow, M. E. Polyamines regulate gap junction communication in connexin 43-expressing cells. Biochem. J. 357, 489–495 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Pegg, A. E. et al. Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem. Soc. Trans. 31, 356–360 (2003).
  Article CAS PubMed Google Scholar
• Williams-Ashman, H. G. & Schenone, A. Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast _S_-adenosylmethionine decarboxylases. Biochem. Biophys. Res. Commun. 46, 288–295 (1972).
  Article CAS PubMed Google Scholar
• Mamont, P. S. et al. α-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in culture. Proc. Natl Acad. Sci. USA 73, 1626–1630 (1976).
  Article CAS PubMed PubMed Central Google Scholar
• Bey, P. et al. Analogues of ornithine as inhibitors of ornithine decarboxylase. New deductions concerning the topography of the enzyme's active site. J. Med. Chem. 21, 50–55 (1978).
  Article CAS PubMed Google Scholar
• Doua, F. & Yapo, F. B. Human trypanosomiasis in the Ivory Coast: therapy and problems. Acta Trop. 54, 163–168 (1993).
  Article CAS PubMed Google Scholar
• Seiler, N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr. Drug Targets 4, 537–564 (2003).
  Article CAS PubMed Google Scholar
• Bitonti, A. J. et al. Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase. J. Biol. Chem. 265, 382–388 (1990).
  CAS PubMed Google Scholar
• Seiler, N., Duranton, B. & Raul, F. The polyamine oxidase inactivator MDL 72527. Prog. Drug Res. 59, 1–40 (2002).
  CAS PubMed Google Scholar
• Mamont, P. S., Claverie, N. & Gerhart, F. Fluorine-containing polyamines: biochemistry and potential applications. Adv. Exp. Med. Biol. 250, 691–706 (1988).
  Article CAS PubMed Google Scholar
• McCann, P. P. & Pegg, A. E. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther. 54, 195–215 (1992).
  Article CAS PubMed Google Scholar
• McCann, P. P., Pegg, A. E. & Sjoerdsma, A. Inhibition of Polyamine Metabolism, Biological Significance and Basis for New Therapies (Academic, Orlando, 1987).
  Google Scholar
• Lawson, K. R., Ignatenko, N. A., Piazza, G. A., Cui, H. & Gerner, E. W. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev. 9, 1155–1162 (2000).
  CAS PubMed Google Scholar
• Weeks, C. E., Herrmann, A. L., Nelson, F. R. & Slaga, T. J. α-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc. Natl Acad. Sci. USA 79, 6028–6032 (1982). Demonstrated that DFMO inhibited chemically induced skin carcinogenesis by a mechanism affecting tumour promotion. Provided the first evidence from animal models supporting the rationale for DFMO as a chemopreventive agent.
  Article CAS PubMed PubMed Central Google Scholar
• Meyskens, F. L. Jr et al. Effect of α-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J. Natl Cancer Inst. 90, 1212–1218 (1998). Demonstrated the safety of DFMO and its potent biochemical effect on polyamine content in human colon tissue over a 1-year period; a critical study for planning of Phase III trials.
  Article CAS PubMed Google Scholar
• Rao, C. V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G. & Reddy, B. S. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16 α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res. 51, 4528–4534 (1991).
  CAS PubMed Google Scholar
• Croghan, M. K., Aickin, M. G. & Meyskens, F. L. Dose-related α-difluoromethylornithine ototoxicity. Am. J. Clin. Oncol. 14, 331–335 (1991).
  Article CAS PubMed Google Scholar
• Pasic, T. R., Heisey, D. & Love, R. R. α-difluoromethylornithine ototoxicity. Chemoprevention clinical trial results. Arch. Otolaryngol. Head Neck Surg. 123, 1281–1286 (1997).
  Article CAS PubMed Google Scholar
• Doyle, K. J., McLaren, C. E., Shanks, J. E., Galus, C. M. & Meyskens, F. L. Effects of difluoromethylornithine chemoprevention on audiometry thresholds and otoacoustic emissions. Arch. Otolaryngol. Head Neck Surg. 127, 553–558 (2001).
  Article CAS PubMed Google Scholar
• Mitchell, M. F. et al. Phase I dose de-escalation trial of α-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia. Clin. Cancer Res. 4, 303–310 (1998).
  CAS PubMed Google Scholar
• Carbone, P. P. et al. Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants. Cancer Epidemiol. Biomarkers Prev. 10, 657–661 (2001).
  CAS PubMed Google Scholar
• Love, R. R. et al. Randomized phase I chemoprevention dose-seeking study of α-difluoromethylornithine. J. Natl Cancer Inst. 85, 732–737 (1993).
  Article CAS PubMed Google Scholar
• Alberts, D. S. et al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol. Biomarkers Prev. 9, 1281–1286 (2000). Clinical study showing efficacy of DFMO in the treatment of actinic keratoses in humans.
  CAS PubMed Google Scholar
• Boyle, J. O., Meyskens, F. L. Jr, Garewal, H. S. & Gerner, E. W. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev. 1, 131–135 (1992).
  CAS PubMed Google Scholar
• Simoneau, A. R., Gerner, E. W., Phung, M., McLaren, C. E. & Meyskens, F. L. Jr. α-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial. J. Natl Cancer Inst. 93, 57–59 (2001).
  Article CAS PubMed Google Scholar
• Fabian, C. J. et al. A phase II breast cancer chemoprevention trial of oral α-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin. Cancer Res. 8, 3105–3117 (2002).
  CAS PubMed Google Scholar
• Meyskens, F. L. Jr et al. Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps. J. Natl Cancer Inst. 86, 1122–1130 (1994). Clinical study that used a novel dose de-escalation design to identify the lowest does of DFMO that still caused the desired biochemical effect (polyamine depletion) in the target tissue.
  Article PubMed Google Scholar
• Levy, G. N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11, 234–247 (1997).
  Article CAS PubMed Google Scholar
• Oshima, M. et al. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803–809 (1996).
  Article CAS PubMed Google Scholar
• Phillips, R. K. et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50, 857–860 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Bishop-Bailey, D., Calatayud, S., Warner, T. D., Hla, T. & Mitchell, J. A. Prostaglandins and the regulation of tumor growth. J. Environ. Pathol. Toxicol. Oncol. 21, 93–101 (2002).
  Article CAS PubMed Google Scholar
• Hughes, A., Smith, N. I. & Wallace, H. M. Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cells. Biochem. J. 374, 481–488 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Jacoby, R. F. et al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res. 60, 1864–1870 (2000).
  CAS PubMed Google Scholar
• Meyskens, F. L. Jr et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. Natl Cancer Inst. 86, 539–543 (1994).
  Article PubMed Google Scholar
• Hong, W. K. et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323, 795–801 (1990).
  Article CAS PubMed Google Scholar
• Fisher, B. et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl Cancer Inst. 90, 1371–1388 (1998).
  Article CAS PubMed Google Scholar
• Mitchell, J. L., Hoff, J. A. & Bareyal-Leyser, A. Stable ornithine decarboxylase in a rat hepatoma cell line selected for resistance to α-difluoromethylornithine. Arch. Biochem. Biophys. 290, 143–152 (1991).
  Article CAS PubMed Google Scholar
• Meyskens, F. L. Jr & Szabo, E. How should we move the field of chemoprevention agent development forward in a productive manner. Eur. J. Cancer (in the press).
• Levin, V. A. et al. Phase III randomized study of postradiotherapy chemotherapy with combination α-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin. Cancer Res. 9, 981–990 (2003).
  CAS PubMed Google Scholar
• Lux, G. D., Marton, L. J. & Baylin, S. B. Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science 210, 195–198 (1980). Showed the importance of polyamines in normal intestinal development and repair of damage.
  Article CAS PubMed Google Scholar
• Yarrington, J. T. et al. Intestinal changes caused by DL-α-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase. Exp. Mol. Pathol. 39, 300–316 (1983).
  Article CAS PubMed Google Scholar
• Wang, J. Y. & Johnson, L. R. Luminal polyamines stimulate repair of gastric mucosal stress ulcers. Am. J. Physiol. 259, G584–G592 (1990).
  Article CAS PubMed Google Scholar
• Wang, J. Y. & Johnson, L. R. Polyamines and ornithine decarboxylase during repair of duodenal mucosa after stress in rats. Gastroenterology 100, 333–343 (1991).
  Article CAS PubMed Google Scholar
• Babal, P., Manuel, S. M., Olson, J. W. & Gillespie, M. N. Cellular disposition of transported polyamines in hypoxic rat lung and pulmonary arteries. Am. J. Physiol. Lung Cell Mol. Physiol. 278, L610–L617 (2000).
  Article CAS PubMed Google Scholar
• Ahuja, V., Tantry, U., Park, J. & Barbul, A. Effect of difluoromethylornitine,a chemotherapeutic agent, on wound healing. J. Surg. Res. 114, 308–309 (2003).
  Article Google Scholar
• Calandra, R. S., Rulli, S. B., Frungieri, M. B., Suescun, M. O. & Gonzalez-Calvar, S. I. Polyamines in the male reproductive system. Acta Physiol. Pharmacol. Ther. Latinoam. 46, 209–222 (1996).
  CAS PubMed Google Scholar
• Guha, S. K. & Janne, J. Decarboxylation of ornithine and adenosymethionine in rat ovary during pregnancy. Acta Endocrinol. (Copenh.) 81, 793–800 (1976).
  Article CAS Google Scholar
• Hoshiai, H., Lin, Y. C., Loring, J. M., Perelle, B. A. & Villee, C. A. Ornithine decarboxylase activity and polyamine content of the placenta and decidual tissue in the rat. Placenta 2, 105–116 (1981).
  Article CAS PubMed Google Scholar
• Min, S. H. et al. Altered levels of growth-related and novel gene transcripts in reproductive and other tissues of female mice overexpressing spermidine/spermine _N_1-acetyltransferase (SSAT). J. Biol. Chem. 277, 3647–3657 (2002).
  Article CAS PubMed Google Scholar
• Humphreys, M. H., Etheredge, S. B., Lin, S. Y., Ribstein, J. & Marton, L. J. Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the rat. Am. J. Physiol. 255, F270–F277 (1988).
  CAS PubMed Google Scholar
• Mackintosh, C. A., Feith, D. J., Shantz, L. M. & Pegg, A. E. Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy. Biochem. J. 350, 645–653 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Park, M. H., Lee, Y. B. & Joe, Y. A. Hypusine is essential for eukaryotic cell proliferation. Biol. Signals 6, 115–123 (1997).
  Article CAS PubMed Google Scholar
• Schnier, J., Schwelberger, H. G., Smit-McBride, Z., Kang, H. A. & Hershey, J. W. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 11, 3105–3114 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Kang, H. A. & Hershey, J. W. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J. Biol. Chem. 269, 3934–3940 (1994).
  CAS PubMed Google Scholar
• Tome, M. E., Fiser, S. M., Payne, C. M. & Gerner, E. W. Excess putrescine accumulation inhibits the formation of modified eukaryotic initiation factor 5A (eIF-5A) and induces apoptosis. Biochem. J. 328, 847–854 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Bevec, D. & Hauber, J. Eukaryotic initiation factor 5A activity and HIV-1 Rev function. Biol. Signals 6, 124–133 (1997).
  Article CAS PubMed Google Scholar
• Zuk, D. & Jacobson, A. A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. EMBO J. 17, 2914–2925 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Hayashi, S., Murakami, Y. & Matsufuji, S. Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem. Sci. 21, 27–30 (1996).
  Article CAS PubMed Google Scholar
• Matsufuji, S., Matsufuji, T., Wills, N. M., Gesteland, R. F. & Atkins, J. F. Reading two bases twice: mammalian antizyme frameshifting in yeast. EMBO J. 15, 1360–1370 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Tsuji, T. et al. Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme. Oncogene 20, 24–33 (2001).
  Article CAS PubMed Google Scholar
• Casero, R. A. Jr & Pegg, A. E. Spermidine/spermine _N_1-acetyltransferase: the turning point in polyamine metabolism. FASEB J. 7, 653–661 (1993).
  Article CAS PubMed Google Scholar
• Thomas, T. & Thomas, T. J. Polyamine metabolism and cancer. J. Cell. Mol. Med. 7, 113–126 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Eimer, S., Lakowski, B., Donhauser, R. & Baumeister, R. Loss of spr-5 bypasses the requirement for the C. elegans presenilin sel-12 by derepressing hop-1. EMBO J. 21, 5787–5796 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hixson, L. J., Emerson, S. S., Shassetz, L. R. & Gerner, E. W. Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa. Cancer Epidemiol. Biomarkers Prev. 3, 317–323 (1994).
  CAS PubMed Google Scholar
• Xie, X., Gillies, R. J. & Gerner, E. W. Characterization of a diamine exporter in Chinese hamster ovary cells and identification of specific polyamine substrates. J. Biol. Chem. 272, 20484–20489 (1997).
  Article CAS PubMed Google Scholar
• Wang, Y. et al. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem. Biophys. Res. Commun. 304, 605–611 (2003).
  Article CAS PubMed Google Scholar
• Cornbleet, M. A. et al. Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesis. Cancer Chemother. Pharmacol. 23, 348–352 (1989).
  Article CAS PubMed Google Scholar
• Gastaut, J. A. et al. Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (α difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG). Cancer Chemother. Pharmacol. 20, 344–348 (1987).
  Article CAS PubMed Google Scholar
• Wilding, G. et al. Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors. Invest. New Drugs 22, 131–138 (2004).
  Article CAS PubMed Google Scholar
• Thompson, I. M. et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349, 215–224 (2003).
  Article CAS PubMed Google Scholar